Christopher Staten
2021
In 2021, Christopher Staten earned a total compensation of $532.3K as Former Interim Chief Financial Officer at Aerie Pharmaceuticals.
Compensation breakdown
| Option Awards | $125,464 |
|---|---|
| Salary | $285,231 |
| Stock Awards | $67,637 |
| Other | $54,007 |
| Total | $532,339 |
Staten received $285.2K in salary, accounting for 54% of the total pay in 2021.
Staten also received $125.5K in option awards, $67.6K in stock awards and $54K in other compensation.
Rankings
In 2021, Christopher Staten's compensation ranked 10,593rd out of 12,415 executives tracked by ExecPay. In other words, Staten earned more than 14.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,593 out of 12,415 | 15th |
Division Manufacturing | 4,679 out of 5,505 | 15th |
Major group Chemicals And Allied Products | 2,101 out of 2,375 | 12th |
Industry group Drugs | 1,865 out of 2,096 | 11th |
Industry Biological Products, Except Diagnostic Substances | 410 out of 449 | 9th |
Source: SEC filing on April 26, 2022.
Staten's colleagues
We found seven more compensation records of executives who worked with Christopher Staten at Aerie Pharmaceuticals in 2021.
2021
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
2021
Raj Kannan
Aerie Pharmaceuticals
Chief Executive Officer
2021
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2021
Casey Kopczynski
Aerie Pharmaceuticals
Chief Innovation Officer, Head of Research and External Innovation
2021
John LaRocca
Aerie Pharmaceuticals
General Counsel
2021
Benjamin McGraw
Aerie Pharmaceuticals
Former Interim Executive Chair
2021
Richard Rubino
Aerie Pharmaceuticals